Detalhe da pesquisa
1.
Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment.
CNS Spectr
; 28(1): 90-97, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657638
2.
Clinical benefits of vortioxetine 20 mg/day in patients with major depressive disorder.
CNS Spectr
; 28(6): 693-701, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070529
3.
Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study.
Pharmacopsychiatry
; 55(3): 148-156, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847610
4.
Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12-Week, Randomized, Controlled Study.
Mov Disord
; 36(10): 2413-2418, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117788
5.
Efficacy of vortioxetine in working patients with generalized anxiety disorder.
CNS Spectr
; 24(2): 249-257, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29081307
6.
Efficacy of vortioxetine in working patients with generalized anxiety disorder- ERRATUM.
CNS Spectr
; 24(2): 275, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880074
7.
The Motivation and Energy Inventory (MEI): Analysis of the clinically relevant response threshold in patients with major depressive disorder and emotional blunting using data from the COMPLETE study.
J Affect Disord
; 323: 547-553, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36395989
8.
Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability.
J Affect Disord
; 328: 345-354, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708956
9.
A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.
Int J Neuropsychopharmacol
; 15(5): 589-600, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767441
10.
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder.
Neuropsychiatr Dis Treat
; 17: 575-585, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654400
11.
Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
J Affect Disord
; 283: 472-479, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516560
12.
Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting.
J Affect Disord
; 294: 924-931, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378539
13.
Efficacy of vortioxetine in patients with major depressive disorder reporting childhood or recent trauma.
J Affect Disord
; 263: 258-266, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818787
14.
Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder.
Curr Med Res Opin
; 36(5): 875-882, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990207
15.
Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders.
J Affect Disord
; 227: 787-794, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29689693
16.
Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia.
Sleep
; 30(3): 281-7, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17425224
17.
Effectiveness of long-term vortioxetine treatment of patients with major depressive disorder.
Eur Neuropsychopharmacol
; 27(9): 877-884, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693903
18.
The effect of vortioxetine on overall patient functioning in patients with major depressive disorder.
Brain Behav
; 7(3): e00622, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28293465
19.
Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder.
J Clin Psychiatry
; 78(1): 115-121, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27780334
20.
Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study.
Neuropsychiatr Dis Treat
; 13: 2151-2165, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28860772